Anti-tumor necrosis factor (TNF) drugs are the newest class of therapies used for treating inflammatory diseases, such as Crohn’s disease, psoriasis and rheumatoid arthritis (RA). Our last post discussed the benefits of treating RA with a combination of anti-TNF medication and methotrexate. But there is new research that indicates concern for treating certain individuals [...]
The FDA has received 30 reports of cancer in children under the age of 18 who had been treated for JIA with anti-TNF drugs along with other medications, such as methotrexate, or similar immunosuppressant drugs. [...]
A new one time treatment is being tested by scientists in Great Britain which could potentially “switch off” rheumatoid arthritis. The researchers are theorizing that the drug will turn off the immune system response that is the cause of the debilitating disease. This may put the RA patient into remission for years, [...]
In a properly functioning immune system, the immune cells are supposed to die after attacking an invading bacteria or virus. This process of cell death is called apoptosis.
“In apoptosis, a cell quietly dies off and gets removed from the system. That’s the way our body has of renewing itself all the time. [...]
Scientists have found that in countries where parasitic infections are common the incidence of autoimmune diseases is relatively small. One hypothesis is that a chemical secreted by parasitic worms may have anti-inflammatory properties. If true, it may lead to a potential treatment for rheumatoid arthritis. [...]
According to a drug trial that was presented at the American College of Rheumatology in San Francisco indicates that methotrexate, when used in combination with tocilizumab, resulted in remission in 47% of the patients. This compares to only 8% for patients on methotrexate alone. [...]
A novel new drug, based on the commonly used prednisone, has been recommended for European regulatory approval for treatment of morning stiffness resulting from rheumatoid arthritis. [...]